ClinicalTrials.gg
DrugBiological

Interferon alpha-2 clinical trials

Also written Intron A, Interferon Alfa-2b and Intron-A.

studies test it
83
open now
1
in phase 3
22
first study started
1994

How each study uses Interferon alpha-2 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Interferon alpha-2 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
4 Jun 1986 · INTRON A · BLA 103132 (FDA, Drugs@FDA)
European Union
9 Mar 2000 · IntronA · EMEA/H/C/000281 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Recombinant Interferon Alfa-2b
16
Alfatronol
5
Glucoferon
5
Heberon Alfa
5
IFN alpha-2B
5

Brand

Intron A
19
Intron-A
4
Roferon-A
4

Other names

Interferon Alfa-2b
18
Interferon alfa-2a
9
interferon alpha 2b
1

Studies by the year they started

76 studies that test it; most in 2007 (10)

Studies that test Interferon alpha-2, by start year
YearStudies
19942
19951
19961
19971
19983
19991
20002
20013
20022
20032
20044
20057
20064
200710
20083
20093
20101
20114
20123
20134
20144
20151
20171
20184
20193
20242

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
20
Phase 2
39
Phase 3
22
Phase 4
10
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 75

National Cancer Institute (NCI) (7) · Roswell Park Cancer Institute (6) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · M.D. Anderson Cancer Center (4) · Hoffmann-La Roche (4) · Foundation for Liver Research (2) · Kirby Institute (2) · Case Comprehensive Cancer Center (2)

Often tested with

Tested in the same studies.

Ribavirin (9) · poly(I).poly(c12,U) (6) · Celecoxib (6) · Bevacizumab (4) · Peginterferon alfa-2a (4) · Ipilimumab (2) · Cyclophosphamide (2) · Paclitaxel (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Interferon alpha-2 is the comparator. A study of two new drugs counts under both.

  • 1Pembrolizumab · National Cancer Institute (NCI)
  • 1Bomedemstat · Merck Sharp & Dohme LLC · next primary completion Jul 2027
Reaching primary completion within a year · 1

Studies that test Interferon alpha-2.

Studies

Open first, then newest update. How each study uses Interferon alpha-2 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 83

See all 83 studies that test Interferon alpha-2 →

Given beside what is tested · 37 — Interferon alpha-2 is usual care or a partner of the new treatment

Showing 20 of 37.

As the comparator · 16 — what is tested is compared with Interferon alpha-2

Codes

What other systems call Interferon alpha-2 · ClinicalTrials.gg INT006658

  • MeSH (NLM) D000077190Interferon alpha-2Confirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 43K1W2T1M6INTERFERON ALFA-2BConfirmed FDA, NLM
  • RxNorm 5880One source FDA

Also registered as interferon alfa-2a (UNII 47RRR83SK7 · RxNorm 5879).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.